These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 37029861)
1. Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm. Fukuchi K; Koyama D; Takada M; Mori H; Hayashi K; Asano N; Sato Y; Fukatsu M; Takano M; Takahashi H; Shirado-Harada K; Kimura S; Yamamoto T; Ikezoe T Int J Hematol; 2023 Oct; 118(4):489-493. PubMed ID: 37029861 [TBL] [Abstract][Full Text] [Related]
2. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report. Dang X; Zhou D; Meng L; Bi L J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792 [TBL] [Abstract][Full Text] [Related]
3. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review. Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479 [TBL] [Abstract][Full Text] [Related]
4. Sex-Biased Togami K; Chung SS; Madan V; Booth CAG; Kenyon CM; Cabal-Hierro L; Taylor J; Kim SS; Griffin GK; Ghandi M; Li J; Li YY; Angelot-Delettre F; Biichle S; Seiler M; Buonamici S; Lovitch SB; Louissaint A; Morgan EA; Jardin F; Piccaluga PP; Weinstock DM; Hammerman PS; Yang H; Konopleva M; Pemmaraju N; Garnache-Ottou F; Abdel-Wahab O; Koeffler HP; Lane AA Cancer Discov; 2022 Feb; 12(2):522-541. PubMed ID: 34615655 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088 [TBL] [Abstract][Full Text] [Related]
6. Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm. Szczepaniak A; Machnicki M; Gniot M; Pępek M; Rydzanicz M; Płoski R; Kaźmierczak M; Stokłosa T; Lewandowski K Int J Hematol; 2019 Jul; 110(1):102-106. PubMed ID: 30977107 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700 [TBL] [Abstract][Full Text] [Related]
8. Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review. Wang Q; Zhao Y; Zang X; Zhou G; Liu Y; Feng Q; Li X; Wang W; Dong X; Liu X; Peng J; Liu C Ann Hematol; 2024 Mar; 103(3):999-1005. PubMed ID: 38285081 [TBL] [Abstract][Full Text] [Related]
9. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm. Zhang X; Sun J; Yang M; Wang L; Jin J Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682 [TBL] [Abstract][Full Text] [Related]
10. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy. Riaz W; Zhang L; Horna P; Sokol L Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209 [TBL] [Abstract][Full Text] [Related]
11. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review. Ding Y; Yang J; Lindsey K Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895 [TBL] [Abstract][Full Text] [Related]
12. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy. Wilson NR; Konopleva M; Khoury JD; Pemmaraju N Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167 [TBL] [Abstract][Full Text] [Related]
13. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300 [TBL] [Abstract][Full Text] [Related]
14. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy. Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087 [TBL] [Abstract][Full Text] [Related]
15. Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis. Suma S; Sakata-Yanagimoto M; Nguyen TB; Hattori K; Sato T; Noguchi M; Nannya Y; Ogawa S; Watanabe R; Fujimoto M; Nakamura N; Kusakabe M; Nishikii H; Kato T; Chiba S Int J Hematol; 2018 Oct; 108(4):447-451. PubMed ID: 29705980 [TBL] [Abstract][Full Text] [Related]
20. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body. Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]